Pfenex, Inc.
(NYSE Amex Equities : PFNX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 8.80%68.120.0%$1042.54m
NVAXNovavax, Inc. 8.31%102.20251.8%$828.03m
AMGNAmgen, Inc. 1.15%251.901.3%$701.75m
REGNRegeneron Pharmaceuticals, Inc. 0.92%626.562.5%$669.11m
GILDGilead Sciences, Inc. 1.23%77.261.0%$638.57m
BIIBBiogen, Inc. 0.60%280.561.6%$605.19m
VRTXVertex Pharmaceuticals, Inc. 0.13%294.841.9%$476.15m
VXRTVaxart, Inc. 27.44%10.170.0%$365.64m
ILMNIllumina, Inc. 1.59%376.133.5%$305.97m
ALXNAlexion Pharmaceuticals, Inc. 0.52%109.392.0%$218.32m
BMRNBioMarin Pharmaceutical, Inc. 1.79%128.324.3%$210.52m
SGENSeattle Genetics, Inc. 0.27%174.826.1%$192.91m
SRNESorrento Therapeutics, Inc. -0.99%7.981.8%$190.94m
BNTXBioNTech SE 16.13%81.710.0%$181.80m
IMMUImmunomedics, Inc. 1.55%41.9611.0%$179.74m

Company Profile

Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.